Matías J Alet: Proud to Present the CAMINA Project on Argentina’s National Stroke Center Mapping at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I had the great opportunity to participate in the European Stroke Organisation Conference 2026 (ESOC) in Maastricht.
During the conference, I presented in the symposium ‘Opportunities for improving AIS patient outcomes’, where I shared the Argentine perspective on switching to tenecteplase for acute ischemic stroke treatment.
Many thanks to Boehringer Ingelheim and Rachel Emerson-Stadler for the opportunity.
I was also proud to present the CAMINA Project, our national mapping of stroke care centers and reperfusion capacity in Argentina.
This work aims to better understand the availability of key stroke resources across the country and to identify opportunities to improve access to time-sensitive acute stroke treatments.
Thanks to Julieta Rosales, Guadalupe Bruera, Leonardo Augusto Carbonera and all the collaborators from Argentine Neurological Society.
ESOC 2026 was also a valuable opportunity to catch up and reconnect with colleagues and friends from the three cohorts of the World Stroke Organization Future Stroke Leaders Programme, and to exchange ideas and future projects for the World Stroke Academy with my friends Laura Ceci Galanos and Octavio Marques Pontes-Neto.
I also had the opportunity to discuss future collaborative projects with the International Cerebral Venous Thrombosis Consortium and Jonathan Coutinho.
As always, I am especially grateful to Sheila Cristina Ouriques Martins for her leadership and mentorship, and Angels Initiative and Belén Velázquez, MSc for their continuous support in advancing stroke care across our region and beyond.
Let’s continue supporting stroke care improvement in Argentina and the region.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week